Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1360-0443.2009.02684.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The correlation between relative peripheral refraction and myopia progression: A commentary on the utility of retinoscopy for peripheral refraction assessment.
J Optom
January 2025
Palani, Tamil Nadu 624601, India; Department of Ophthalmology, Jiwan Jyoti Christian Hospital, Robertsganj, Uttar Pradesh 231216, India. Electronic address:
Commentary on Sun and Tang: Measurement assessment and validity in problematic smartphone use.
Addiction
January 2025
School of Medicine, University of Nottingham, Nottingham, UK.
Echocardiographic assessment of left ventricular filling pressures in atrial fibrillation: are we getting any closer?
Eur Heart J Cardiovasc Imaging
January 2025
University of Medicine and Pharmacy "Carol Davila", Bucharest, Romania.
Let us pay more attention to performing coronary function assessment for multivessels!
Cardiovasc Diagn Ther
December 2024
Department of Cardiovascular Medicine, JR Hiroshima Hospital, Higashi-ku, Hiroshima, Japan.
Seizing the opportunity to therapeutically address neuronal hyperexcitability in Alzheimer's disease.
J Alzheimers Dis
January 2025
Department of Pharmaceutics, University of Washington, Seattle, WA, USA.
Seizures in people with Alzheimer's disease are increasingly recognized to worsen disease burden and accelerate functional decline. Harnessing established antiseizure medicine discovery strategies in rodents with Alzheimer's disease associated risk genes represents a novel way to uncover disease modifying treatments that may benefit these Alzheimer's disease patients. This commentary discusses the recent evaluation by Dejakaisaya and colleagues to assess the antiseizure and disease-modifying potential of the repurposed cephalosporin antibiotic, ceftriaxone, in the Tg2576 mouse model.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!